Related Experiment Videos
Screening for neonatal endocrinopathies: rationale, methods and results
Guy Van Vliet1, Paul Czernichow
1Université de Montréal and Endocrinology Service, Hôpital Sainte-Justine, 3175 Côte Ste-Catherine, Montréal H3T 1C5, Québec, Canada. gvanvliet@justine.umontreal.ca
Seminars in Neonatology : SN
|March 12, 2004
Summary
Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia using dried blood spots enables early diagnosis and treatment. This is crucial for preventing cognitive deficits and neonatal deaths, though challenges like false positives exist.
Area of Science:
- Neonatal screening
- Endocrinology
- Public health
Background:
- Congenital hypothyroidism and congenital adrenal hyperplasia require timely diagnosis to prevent severe health outcomes.
- Dried blood spot testing offers a method for early detection of these conditions in newborns.
- Screening programs aim to prevent mental deficiency and neonatal mortality.
Purpose of the Study:
- To highlight the importance of rapid turnaround times in newborn screening programs.
- To discuss the benefits of biochemical screening for congenital hypothyroidism and congenital adrenal hyperplasia.
- To address challenges associated with screening, such as false positives.
Main Methods:
- Measurement of thyrotropin or thyroxine from dried blood spots for congenital hypothyroidism.
- Measurement of 17-hydroxy-progesterone from dried blood spots for congenital adrenal hyperplasia.
- Analysis of screening program efficiency and diagnostic accuracy.
Main Results:
- Early diagnosis through dried blood spot testing prevents mental deficiency in congenital hypothyroidism.
- Screening for congenital adrenal hyperplasia prevents neonatal deaths, but clinical awareness is variable.
- Biochemical screening facilitates earlier treatment for both conditions.
Conclusions:
- Rapid screening is vital for preventing long-term cognitive issues in congenital hypothyroidism.
- While effective, screening for 21-hydroxylase deficiency faces challenges with false positives, impacting universal adoption.
- Dried blood spot analysis is a key tool in neonatal screening for endocrine disorders.